Pammer Johannes, Reinisch Christine, Birner Peter, Pogoda Kristin, Sturzl Michael, Tschachler Erwin
Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
Lab Invest. 2006 Oct;86(10):997-1007. doi: 10.1038/labinvest.3700461. Epub 2006 Aug 7.
Although the antiangiogenic activity of type I interferons (IFN) is well known, the mechanism by which it occurs is unclear. In the present study, we have investigated effects of short-term and long-term IFN-alpha exposure on different types of endothelial cells (EC). Short-term IFN-alpha treatment resulted in a distinct reduction of apoptosis of serum and growth factor starved HUVEC and HDMEC. This was accompanied by a strong upregulation of the IFN inducible guanylate binding protein-1 (GBP-1) whereas no consistent regulation of several known antiapoptotic proteins was evident. Stable transfection of HUVEC with an expression vector for GBP-1 mimicked the protective effect of IFN-alpha, suggesting that GBP-1 may contribute to the inhibition of apoptosis. When IFN-alpha, together with serum and EC growth factors, was present continuously a decrease of population doublings by more than 40% was observed in both HDMEC and HCAEC. In addition, the cells displayed a senescent phenotype significantly earlier than control cells and showed an increased adherence for monocytes. Our findings suggest that the antiangiogenic effect of IFN-alpha is mediated by inducing EC senescence rather than EC apoptosis. Furthermore IFN-alpha released in chronic inflammatory conditions might contribute via its prosenescent activity to the pathogenesis of atherosclerosis.
尽管I型干扰素(IFN)的抗血管生成活性已广为人知,但其发生机制尚不清楚。在本研究中,我们研究了短期和长期暴露于IFN-α对不同类型内皮细胞(EC)的影响。短期IFN-α处理导致血清和生长因子饥饿的人脐静脉内皮细胞(HUVEC)和人真皮微血管内皮细胞(HDMEC)凋亡明显减少。这伴随着IFN诱导的鸟苷酸结合蛋白-1(GBP-1)的强烈上调,而几种已知的抗凋亡蛋白没有一致的调节。用GBP-1表达载体稳定转染HUVEC模拟了IFN-α的保护作用,表明GBP-1可能有助于抑制细胞凋亡。当IFN-α与血清和内皮细胞生长因子持续存在时,在HDMEC和人冠状动脉内皮细胞(HCAEC)中均观察到群体倍增减少超过40%。此外,这些细胞比对照细胞更早地表现出衰老表型,并显示出对单核细胞的粘附增加。我们的研究结果表明,IFN-α的抗血管生成作用是通过诱导内皮细胞衰老而不是内皮细胞凋亡来介导的。此外,在慢性炎症条件下释放的IFN-α可能通过其促衰老活性促进动脉粥样硬化的发病机制。